Previously, antibodies raised against T3SS translocators, CopB and CopD, were reported to inhibit chlamydial infection in vitro, suggesting that antibodies directed at these proteins block an essential component of T3SS virulence [18]. Here, ARCN1 is linked to chlamydia trachomatis infectious disease.